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K-ATPaseFXYD2 is a membrane protein responsible for regulating the function of the Na,K-ATPase in mammalian kidney
epithelial cells. Here we report the structure of FXYD2b, one of two splice variants of the protein, determined by
NMR spectroscopy in detergentmicelles. Solid-state NMR characterization of the protein embedded in phospho-
lipid bilayers indicates that several arginine side chains may be involved in hydrogen bond interactions with the
phospholipid polar head groups. The structure and the NMR data suggest that FXYD2b could regulate the Na,K-
ATPase by modulating the effective membrane surface electrostatics near the ion binding sites of the pump. This
article is part of a Special Issue entitled: NMR Spectroscopy for Atomistic Views of Biomembranes and Cell Sur-
faces. Guest Editors: Lynette Cegelski and David P. Weliky.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The critical balance of Na+ and K+ ion concentrations across cell
membranes is maintained primarily by the Na/K-ATPase, an integral
membrane enzyme complex that hydrolyses intracellular ATP to gener-
ate the energy required to exchange three Na+ ions for two K+ ions
across the plasma membrane [1–3]. The enzyme's activity is regulated
by its three subunits – a catalytic α subunit, an auxiliary β subunit and
a regulatory γ subunit, also known as FXYD protein due to a conserved
amino acid sequence in its N-terminus. The expression of FXYD genes
is tissue-speciﬁc, cell-speciﬁc and developmentally regulated. The
proteins are prevalent in the early stages of fetal life, in tissues that spe-
cialize in ﬂuid or solute transport or that are electrically excitable. Their
association with the Na,K-ATPase induces speciﬁc changes in the
enzyme's kinetics and afﬁnity for Na+, K+ and ATP [3–6]. Several
FXYD familymembers have been linkedwithmajor human diseases, in-
cluding heart failure (FXYD1) [7], hypomagnesemia (FXYD2) [8], cancer
(FXYD3, FXYD5) [9,10], and schizophrenia (FXYD6) [11], and represent
attractive targets for therapeutic development.
Although the FXYD proteins typically possess a single transmem-
brane helix and are relatively small, they are all encoded by genes
with as many as nine exons [5]. Interestingly, the protein structures
mirror the intron–exon arrangements of their corresponding genes,
suggesting that discrete structured domainsmay have evolved to conferctroscopy for Atomistic Views of
egelski and David P. Weliky.
1 858 713 6268.different functional properties in various physiological settings [12]. The
family members share a core homology of 35 conserved amino acids, in
and around a single transmembrane segment (Fig. 4A). The short signa-
ture motif, PFXYD (Pro, Phe, X, Tyr, Asp) is highly conserved in all
known mammalian proteins, with residue X usually occupied by Tyr,
but also Thr, Glu, or His. Conserved basic residues ﬂank the transmem-
brane region, the extracellular N-termini are acidic, and the cytoplasmic
C-termini are basic. However, outside of this homology region there is
little sequence conservation among the family members. The distinct
functionalities of FXYD proteins on the Na,K-ATPase's rate constant
and afﬁnities for Na+, K+ and ATP are largely ascribed to differences
in their cytoplasmic domains, whose sequences vary widely among
the family members.
FXYD2, the ﬁrst FXYD protein to be identiﬁed as an accessory com-
ponent of the Na,K-ATPase [13,14], inhibits the activity of the pump
by increasing its apparent afﬁnity for bothNa+ andK+ [15–20]. Its func-
tion is modulated by post-translational modiﬁcation [16,18], as well as
by gene splicing andRNAediting,which respectively govern the expres-
sion of two splice variants, FXYD2a and FXYD2b, and of a truncated form
of FXYD2b that is not exported to the plasma membrane [5,13,14,21].
The two splice variants of FXYD2 have identical amino acid sequences,
except in their N-terminal segments, encoded by the ﬁrst exon [22,
23]. Both FXYD2a and FXYD2b are expressed primarily in kidney, albeit
in distinct nephron segments, with FXYD2a in proximal and FXYD2b
distal convoluted tubules [23–26]. The function of FXYD2 has been
implicated in embryonic development [27], while misrouting of the
protein due to the Gly41Arg mutation in the transmembrane segment
has been linkedwith familial hypomagnesemia, a disease characterized
by renal or intestinal Mg2+ loss [8]. The transmembrane span of FXYD2
Table 1
NMR structure statistics for FXYD2b.




Residual dipolar couplings (RDC)
1H–15N RDC 60
Distances




Violations (mean ± s.d.)
Dihedral angle restraints (°) 1.145 ± 0.111
1H–15N RDC restraints (Hz) 0.767 ± 0.029
Distance restraints (Å) 0.144 ± 0.003
Plane distance restraints (Å) 1.311 ± 0.087
Deviations from idealized geometry
Bond lengths (Å) 0.002 ± 0.000
Bond angles (°) 0.461 ± 0.008
Impropers (°) 0.460 ± 0.011
Average pairwise r.m.s.d. (Å)
Backbone 0.181 ± 0.059
Heavy 1.038 ± 0.106
Ramachandran plot statisticsb
Residues in most favored regions (%) 86.3
Residues in additional allowed regions (%) 11.2
Residues in generously allowed regions (%) 2.2
Residues in disallowed regions (%) 0.4
a Evaluated for 10 lowest energy structures out of a total 100 calculated structures.
b Evaluated with the program PROCHECK [49].
300 X.-M. Gong et al. / Biochimica et Biophysica Acta 1848 (2015) 299–306has been implicated inmodulation of the Na,K-ATPase's afﬁnity for Na+
[28], while the N- and C-termini have been implicated in modulation of
the Na+ and K+ afﬁnities [25].
The ﬁrst crystal structure, determined for pig kidney Na,K-ATPase
conﬁrmed that FXYD2 is an integral component of the enzyme complex
and showed that its transmembrane helix associates with αM9, the
ninth transmembrane helix of the α subunit [29]. The α-FXYD associa-
tion is stabilized by the amino acid sequence of αM9, which is highly
conserved among all α subunit isoforms [4], and by a set of highly con-
served FXYD protein residues (Gly28, Gly33, Phe36 and Gly39 in
FXYD2b) that form a distinctive “notch-peg-notch” shape along the
helix length [30]. This intimate α-FXYD transmembrane association is
also observed in the more recent crystal structure of Na,K-ATPase
from pig kidney [31–34] and from shark [35,36], and may be important
for modulating the activity of the enzyme's Na+ binding sites [33].
The signature FXYD motif has been proposed to adopt an extended
hook-like conformation that stabilizes the extracellular region of the β
chain through hydrogen bond and salt bridge contacts [34–36]. However,
the extramembrane regions of the FXYD and β chains are incompletely
and/or poorly deﬁned by the electron densities in the crystal structures
of Na,K-ATPase. The NMR structures of FXYD1 and FXYD4, determined
in micelles, separate from the Na,K-ATPase complex, show that the
FXYD motif adopts a short loosely helical conformation in FXYD1 and a
long well-formed helix in FXYD4 [30,37]. In both structures, the trans-
membrane helix is followed by a short helical extension of conserved
basic residues that anchor it near the membrane–water interface, and a
~10-residue amphipathic C-terminal helix that associates with themem-
brane surface. This helix contains the phosphorylation sites of FXYD1 and
could modulate the electrostatic potential at the membrane surface, near
the Na+/K+ ion binding sites of the Na,K-ATPase α subunit [38].
Here we describe the NMR structure of FXYD2b determined in mi-
celles. Solid-state NMR data, obtained for FXYD2b in magnetically
aligned lipid bilayers, reﬂect the transmembrane orientation of the
protein and show that several arginine side chains are immobilized,
possibly due to hydrogen-bonded interactions with the phospholipid
polar head groups. Such interactions could contribute to themembrane
surface electrostatics and assist the recruitment of speciﬁc negatively
charged phospholipids important for Na,K-ATPase stability and
function.
2. Materials and methods
2.1. Sample preparation
Human FXYD2a and FXYD2b were prepared as described previously
[39]. Brieﬂy, the proteins were each expressed as C-terminal fusions to
His9-TrpΔLE-Met, puriﬁed by Ni-afﬁnity chromatography and then sepa-
rated from the fusion partner by CNBr chemical cleavage. Twomutations
Met1Leu and Cys50Ser (in FXYD2b) or Cys52Ser (in FXYD2a) were
introduced to facilitate cleavage and puriﬁcation. Uniform 13C/15N
isotopic labeling was obtained by supplementing minimal M9 growth
media with 13C-glucose and (15NH4)2SO4 (Cambridge Isotope Laborato-
ries, Andover, MA).
Samples for solutionNMR spectroscopywere prepared by dissolving
pure lyophilized protein in 300 μL of buffer (20mMsodium citrate at pH
5, 10 mM DTT, 10% D2O) containing 500 mM sodium dodecyl sulfate
(SDS) or 150 mM dodecyl-phosphocholine (DPC). For residual dipolar
coupling (RDC) measurements, the samples were weakly aligned in
6.5% polyacrylamide gels bymeans of vertical compression, as described
previously [12].
Magnetically aligned lipid bilayer samples for solid-state NMR
spectroscopy were prepared by dissolving 2–3 mg of pure lyophilized
protein in 1,2-O-dihexyl-sn-glycero-3-phosphocholine (6-O-PC) and
then adding the resulting solution to a dispersion of the longer chain
lipid 1,2-O-ditetradecyl-sn-glycero-3-phosphocholine (14-O-PC) to ob-
tain a molar ratio 3.2 for long-chain to short-chain lipid. The ﬁnalsample, containing 300 mM 14-O-PC in a volume of 180 μL at pH 6.7,
was transferred to a ﬂat-bottomed, 5 mm outer diameter NMR tube
(New Era Enterprises, Vineland, NJ) for NMR studies.
2.2. NMR experiments
Solution NMR experiments were performed at 40 °C on a Bruker
AVANCE 600 MHz spectrometer equipped with a 1H/15N/13C triple-
resonance cryoprobe. Solid-state NMR experiments were performed
on a Bruker AVANCE 500 MHz spectrometer with a home-built 1H/15N
double-resonance 5 mm solenoid coil probe. The NMR data were
processed using NMRPipe [40] and analyzed using Sparky [41].
The 1H/15N/13C two- and three-dimensional solution NMR experi-
ments, for backbone resonance assignments, measurements of reso-
nance intensity and RDC measurements, were performed as described
previously for FXYD1 [30]. Chemical shifts were referenced to the H2O
resonance set to its expected position at 40 °C [42]. Dihedral angles
were derived from analysis of the NMR chemical shifts with the pro-
gram TALOS+ [43]. The 1H/15N one- and two-dimensional oriented
sample (OS) solid-state NMR experimentswere performed as described
previously [44].
To probe the association of FXYD2b with the micelle environment,
we examined the paramagnetic relaxation enhancement (PRE) broad-
ening effect of Mn2+ on the 1H/15N HSQC spectrum of the protein. PRE
restraints were obtained by measuring the resonance intensities in the
1H/15N HSQC spectrum of FXYD2b after addition of increasing amounts
of 1.8 mMMnCl2 to the micelle solution.
2.3. Computational methods
Structure calculationswere performedwith XPLOR-NIH [45,46]. The
structure coordinates and NMR restraints have been deposited in the
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in Table 1.
Two conventional simulated annealing protocolswere used [47], the
ﬁrst for folding 100 structures from an initially extended conformation
and the second for subsequent reﬁnement of 100 structures from the
lowest energy structure of the ﬁrst protocol. Experimental restraints in-
cluded dihedral angles derived from chemical shifts, hydrogen bond
distances derived from 1H/2H exchange, and amide NH bond orienta-
tions derived from RDCs (Table 1). The knowledge-based statistical
torsion angle potential torsionDB was implemented as described previ-
ously [47].
Plane distance restraints, derived from the Mn2+ PRE data, were
implemented in the reﬁnement stage, using the plane distance potential
recently developed for XPLOR-NIH [48], instead of the harmonic coordi-
nate plane restraints thatwe used previously for structure determination
of FXYD1 [30]. Based on the data, backbone N atoms from residues Trp4,
Tyr5 and Leu29 were restrained to one common plane representative of
the extracellular membrane surface, and N atoms from Lys55-Arg57 and
Ser50were restrained to another plane representative of the cytoplasmic
surface. The planes were deﬁned to be perpendicular to the long axis of
the transmembrane helix and the plane distance restrains were imple-
mented loosely (±3 Å).
3. Results and discussion
3.1. Structure of FXYD2b in micelles
The structure of human FXYD2b is shown in Fig. 1. The transmem-
brane helix (h2), spanning residues Gly27-Leu44, is clearly deﬁned by
backbone amide hydrogens that are protected from exchange with
bulk water (Fig. 2A). As observed in the structures of human FXYD1
and rat FXYD4 [30,37], a set of conserved amino acids form a long
groove parallel to the length of the transmembrane helix, delineating
the binding interface with the Na,K-ATPase αM9 helix. The groove is
lined by conserved glycines (Gly28, Gly33, Gly39) and interrupted by
the aromatic ring of Phe36, which protrudes from the transmembrane
helix like a key ready to engage its lock. Helix h2 is preceded by a
short helical segment (h1) that spans residues Phe17-Arg25 and in-
cludes the FXYD signature motif (FYYD in FXYD2).
A short helix (h3), spanning residues Ser45-Ser50, extends beyond
the hydrophobic portion of the transmembrane helix and contains theFig. 1. Structure of FXYD2b determined in micelles. (A) Orthogonal views of the ten lowest en
restraints, derived from the Mn2+ PRE data, are shown as blue spheres. The two planes coinc
(B) Lowest energy structure of FXYD2b showing side chains for arginines and other key residuconserved arginine-rich sequence RRFR of the protein. Helices h2 and
h3 of FXYD2b form a single extended transmembrane helix, while
those of FXYD1 and FXYD4 are separated by a kink that changes helix
direction slightly. Furthermore, FXYD2b lacks the well-deﬁned cyto-
plasmic amphipathic helix observed in FXYD1 and FXYD4, and has
somewhat less structural order in this region. Beyond the helical
regions, the backbone of extracellular Trp4, Tyr5 and Leu6 and cyto-
plasmic Lys55, Arg56, and Arg57 associate with the micelle–water
interface.
Overall, helices h1, h2, and h3 have similar backbone dynamics, with
similar values of 1H/15N heteronuclear NOEs (Fig. 2B), order parameters
(Fig. 2C) and 1H/15N HSQC peak intensities (Fig. 3B). Notably, residues
Trp4-Gly7 in the N-terminus of the protein and residues Lys55-Arg57
in the C-terminal cytoplasmic region, also exhibit restricted dynamics,
while Pro10-Pro16 and the C-terminus are signiﬁcantly more ﬂexible,
with negative values of the 1H/15N NOE and greater peak intensities.
FXYD2a, the longer splice variant, is structurally similar to FXYD2b,
as evidenced by the similarity of their HSQC cross peak chemical shifts
(Fig. 3A). Signiﬁcant chemical shift changes are observed only in
the N-termini where the amino acid sequences of the two proteins dif-
fer (Fig. 3C). Notably, however, the slightly longer N-terminus of
FXYD2a is signiﬁcantlymore dynamic all theway to Gly14, as evidenced
by much greater HSQC peak intensities (Fig. 3B). This feature could be
important for the different physiological functions of FXYD2a and
FXYD2b.
In FXYD2b, the FYYD-spanning helix is oriented at a ~90° angle from
the transmembrane helix. The arrangement of the FYYDmotif helix rel-
ative to themicelle–water interface is consistent with the propensity of
Phe and Tyr to associate with lipids. By contrast, the FXYD motifs of
shark FXYD10 and pig FXYD2 have been proposed to adopt an extended
hook-like structure forming extensive interactions with the extracellu-
lar regions of the β subunit of their respective Na,K-ATPase [34–36].
These regions of the complex are incompletely and/or poorly deﬁned
by the crystallographic data, especially in the case of pig kidney Na,K-
ATPase containing FXYD2 [29,31–34]. However, it is possible that the
extramembrane regions of FXYD proteins adopt different structures in
their isolated states separate from the Na,K-ATPase complex. Several
studies indicate that FXYD proteins can exist separately from the Na,
K-ATPase [50] and associate with different partners, including the
Na+/Ca2+ exchanger and some Ca2+ channels [51,52]. The NMR data
for FXYD2b (Fig. 2B) and other FXYD proteins [30,37,38,53] areergy NMR structures. Amide N atoms whose positions were restricted by plane distance
ide with the micelle–water interface and each contain the amide N atoms of L29 or S50.
es that associate with the micelle interior.
Fig. 2. Summary of structural and dynamic features of FXYD2b inmicelles. Thehelical struc-
ture is outlined above the graphs. (A) Amide 1H/2H exchange proﬁle. (B) Heteronuclear
1H/15N NOEs. (C) Order parameters (S2) derived from TALOS+ analysis of the chemical
shifts. (D) Mn2+ PRE proﬁle showing residual 1H/15N NMR intensity measured after addi-
tion of increasing concentrations of MnCl2. Peak intensities were measured in the presence
of increasing concentrations of Mn2+ (see legend). Residual normalized peak intensity is
the ratio of the intensity measured without Mn2+ to that measured in the presence of
Mn2+. Data for the seven Arg backbone sites are labeled.
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teins aremore dynamic, a property that could enable them to adopt dif-
ferent conformations in different settings or in the presence of their
different partners. Structure determination of the whole FXYD protein
within the enzyme complex will be needed to understand the precise
conformations and functions of the extramembrane regions with re-
spect to Na,K-ATPase regulation.
No conclusive function has been assigned to the signature FXYD
sequences. The FXYDmotifs of FXYD2 and FXYD10 have been proposed
to stabilize the Na,K-ATPase through interactions with the extracellular
regions of the α and β chains [34–36]. However, recent data argue
against involvement of the FXYD, β and α extramembrane regions in
stabilizing the Na,K-ATPase, and instead, attribute the stabilizing inﬂu-
ence of the FXYD proteins on the Na,K-ATPase primarily to the FXYD
transmembrane helices and to the effects of FXYDproteins in promoting
the interactions of the enzyme with speciﬁc phospholipids, such as
negatively charged phosphatidylserine [54,55]. It is also possible that
the FXYD motif helps stabilize the lipid bilayer membrane structure
surrounding the enzyme complex and/or constitutes a localization
signal.A BLAST (Basic Local Alignment Search Tool) search of the NCBI pro-
tein sequence database, seeded with the short polypeptide sequence
DVDPFYYD, identiﬁes this sequence in numerous proteins from a wide
variety of organisms, including prokaryotes (Fig. 4). Notably, the identi-
ﬁcation of entire FXYD protein sequences within other multi-domain
membrane proteins (identiﬁed with TMHMM [56]) further indicates
that they can have functions beyond Na,K-ATPase regulation.
Interesting examples include the 2174-residue DSCAM protein
(Down syndrome cell adhesion molecule-like protein 1), which con-
tains an entire FXYD protein sequence spanning residues 13–56, the
shorter 343-residue DSCAM, which contains two contiguous entire
FXYD protein sequences spanning residues 24–67 and 91–137, and
the 894-residue serine protease, which also contains an entire FXYD
protein sequence from residues 13–56 (Fig. 4B). Thesemay be classiﬁed
as members of the FXYD family since they share sequence homology
across the FXYD motif as well as the conserved features of the trans-
membrane helix. The FXYDmotif is also found in other membrane pro-
teins (Fig. 4C) and several soluble proteins (Fig. 4D) with various
functions, including GTP-binding proteins, lipoproteins and ankyrin re-
peat proteins. Functional insights may be also attained by careful analy-
sis of other FXYD motif containing proteins as their sequences and
structures become available in the databases.
3.2. Association of FXYD2b with the micelle
The depth of micelle insertion of FXYD2b backbone amide sites is
reﬂected by theMn2+ PRE proﬁle (Fig. 2D). Distance-dependent broad-
ening is observed for peaks from solvent-exposed sites, while residues
associated with the hydrophobic regions of the micelle are less or not
affected. The data mirror the hydrophobic character of the micelle-
associated residues. Addition of MnCl2 results in substantial line broad-
ening and disappearance of peaks from the N- and C-termini as well as
from helix h1. By contrast, peaks from helix h2 retain close to their full
intensity in the presence of Mn2+, consistent with the membrane-
embedded topology of this segment. The PRE data also mirror the pro-
ﬁle of backbone dynamics (Fig. 2B) with micelle-associated sites
exhibiting more restricted mobility than water-exposed sites, and
water-exposed regions (Pro10-Pro16 and the C-terminus) exhibiting
enhanced mobility.
Notably, cross peaks from residues Trp4-Gly7 and Lys55-Arg57 also
retain appreciable intensity at high Mn2+ concentrations. These sites
appear protected from interaction with aqueous Mn2+ to a similar ex-
tent as Leu29 and Ser50 ﬂanking the transmembrane helix, indicating
that they are buried at a similar depth within the micelle. The data
effectively restrain the backbone of extracellular Trp4, Tyr5 and Leu6
and cytoplasmic Lys55, Arg56, andArg57 to themicelle–water interface.
The aliphatic side chains of arginines and lysines are frequently found
embedded in membranes with their positively charge groups reaching
toward the membrane–water interface where they can hydrogen
bond with the lipid phosphate head groups [59]. The 1H/15N HSQC
peak from the indole group of Trp4 also resists complete obliteration
by Mn2+, consistent with its insertion in the hydrophobic micelle, and
the orientation of thehydrophobic side chain of Leu6 reﬂects its propen-
sity for membrane insertion.
3.3. Characterization of the arginine side chains
FXYD2b contains seven arginines: Arg3 just before the Trp4-Leu6
micelle-associated segment, Arg25 located after the FYYD motif near
the extracellular membrane–water interface, Arg46, Arg47 and Arg49
located at the end of the transmembrane helix near the cytoplasmic
membrane–water interface, and Arg56 and Arg57 in the micelle-
associated region of the C-terminus. All of these may be expected to
interact appreciably with the membrane since their backbone amide
sites exhibit 1H/15N HSQC signals with protection from Mn2+ PRE
broadening (Fig. 2D).
Fig. 3.Comparison between FXYD2b and FXYD2a inmicelles. (A) 1H/15NHSQC spectra of FXYD2a (red) and FXYD2b (black) in SDS. (B)Normalized 1H/15NHSQCpeak intensitiesmeasured
for FXYD2b (black) or FXYD2a (red). (C) Total difference in 1H and 15N chemical shifts between FXYD2a and FXYD2b (Δδtot= [(ΔδH)2+ (ΔδN/5)2]1/2).ΔδN is scaled by 1/5 to account for
the 5-fold difference between the chemical shift dispersions of 15N and 1H. Asterisks denote cross peaks with Δδtot N1 ppm. Amino acid sequences and numbers at the bottom
correspond to FXYD2b (black) or FXYD2a (red). Differences in the N-termini of the two splice variants are enclosed in the box.
Fig. 4. Amino acid sequence alignment of FXYD homology domains. (A) FXYD family proteins. (B–D) Proteins obtained by BLAST search of the NCBI database against the DVDPYYD
polypeptide sequence. (B)Membrane proteins containing entire FXYD protein sequences, including conserved FXYD and transmembrane (TM)motifs. The Down syndrome cell adhesion
molecule-like protein (DSCAM, ELK11872) contains two FXYD protein sequences, from residues 24–67 and residues 91–137. (C) Othermembrane proteinswith a FXYDmotif preceding a
TM sequence. (D) Soluble protein sequences with a conserved FXYD motif. Alignments were generated with ClustalW [57] in Jalview [58], and rendered with ClustalW coloring. Trans-
membrane sequences were identiﬁed with TMHMM [56]. FASTA-formatted alignments are provided in Supporting materials.
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Fig. 5. Solution and solid-state NMR spectra of uniformly 15N labeled FXYD2b in detergentmicelles and phospholipid bilayers. (A, B) Solution NMR 1H/15NHSQC spectra in SDS (black) and
DPC (red)micelles. Peaks from the seven arginine guanidiniumgroups are enclosed in blue boxes. (A) The 15N frequencies fromArg side chains peaks are not actual but reﬂect the reduced
15N spectral width used to measure the spectra. (B) The spectrum was obtained with full 15N spectral width to observe the correct 1H and 15N frequencies of peaks from arginine
guanidiniumNH sites. (C)Molecular structure of arginine. (D–G) One-and two-dimensional 1H/15N OS solid-state NMR spectra spectra of FXYD2b in lipid bilayers alignedwith themem-
braneperpendicular (D, E) or parallel (F, G) to themagneticﬁeld. Peaks from the transmembrane helix (TM) tracewheel-like patterns (red circles). Peaks assigned to arginineguanidinium
NH groups are enclosed in blue boxes.
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guanidinium NHη signal intensity, consistent with intermediate rota-
tional dynamics of the Arg side chains at this temperature (Fig. 5A). In
the spectra of FXYD2b in SDS, cross peaks from arginine guanidinium
NHε groups are clustered in a region between 7.0 and 7.2 ppm
(Fig. 5A; black). However, the spectra obtained for the protein in DPC
exhibit six well-resolved NHɛ cross peaks between 7.2 and 7.7 ppm
(Fig. 5A; red). Two of these peaks appear signiﬁcantly shifted downﬁeld,
as might be expected for hydrogen-bonded guanidinium groups [60,
61], suggesting that these arginine side chains interact with the DPC
phosphates. This result is substantiated by the solid-state NMR spectra
obtained for uniformly 15N-labeled FXYD2b in magnetically aligned
phospholipid bilayers (Fig. 5D–G), where signiﬁcant resonance intensi-
ty is observed at 15N frequencies (70–90 ppm) associated with arginine
side chains [60–62].
The one-dimensional cross polarization (CP) spectra and the two-
dimensional 1H/15N separated local ﬁeld (SLF) spectra exhibit remark-
able resolution. Resonances from amide sites in the transmembrane
helix (TM) conform to wheel-like patterns in the spectral regions ex-
pected for an α-helix crossing the membrane at an angle of ~20° [63,
64], with 15N frequencies of 150–200 ppm in the spectra from bilayers
aligned perpendicular to magnetic ﬁeld (Fig. 5D, E), or 85–100 ppm in
the spectra from parallel membranes (Fig. 5F, G). For both membrane
alignments, peaks in the central region of the 15N spectrum (100–130
ppm) are assigned to sites with sufﬁcient mobility to cause isotropic
averaging of the 15N chemical shift and 1H–15N dipolar coupling, as
might be expected for the non-helical regions of the protein.
In the case of fully rigid guanidinium groups, each of the seven
arginines in FXYD2b would be expected to contribute three peaks to
the solution and solid-state NMR spectra, one from NHε and two from
NHη groups. However, in the absence of hydrogen bonding or otherimmobilizing inﬂuences, rapid ﬂip rates around the Nε\Cζ bond aver-
age the NHη NMR signals [60,61]. Resonance overlap in the solid-state
NMR spectra of FXYD2b precludes identiﬁcation of the number of
peaks from arginine side chains. However, since these signals display
observable 1H–15N dipolar couplings in the SLF spectra, we infer that
they must emanate from sites that do not undergo rapid isotropic
reorientation.
Notably, both the 1H–15N dipolar couplings and the 15N chemical
shift frequencies of these peaks change with the overall magnetic align-
ment of the lipid bilayermembrane in themagneticﬁeld, indicating that
the Arg side chains themselves adopt preferred orientations relative to
the lipid bilayer. Since FXYD2b contains no other N-bearing side chains
that would resonate in this region of the spectrum, we conclude that at
least some of the arginine side chains are sufﬁciently immobilized to
yield orientation-dependent solid-state NMR signals. Such immobiliza-
tion could result from hydrogen bond formation between arginine side
chains and the lipid phosphate or polar head groups.
3.4. Implications for function
The crystal structures of pig kidney Na,K-ATPase highlight a highly
electropositive region near the cytoplasmic membrane surface and the
Na+/K+ ion binding sites of the α subunit. This region is composed of
arginine and lysine residues located at the cytoplasmic ends and
connecting loops of the α subunit's transmembrane helices, including
three arginines that were proposed to constitute a voltage-sensing
module [29]. To examine the location of FXYD2 arginines in the context
of the Na,K-ATPase, we generated a model of the α/β/FXYD2b complex
by replacing the coordinates of the transmembrane helix of endogenous
FXYD2 in the recent crystal structure of Na,K-ATPase from pig kidney
[34] with those of full-length FXYD2b determined by NMR in this
Fig. 6. Structural model of theα/β/FXYD2b complex. The model was generated by replac-
ing the coordinates of the transmembrane helix of endogenous FXYD2 in the crystal struc-
ture of Na,K-ATPase from pig kidney [34] with those of full-length FXYD2b determined by
NMR. FXYD2b (light blue) associates with helix M9 of the α subunit (gray). FXYD2b argi-
nine and lysine side chains contribute signiﬁcant positive charge (+) to the cytoplasmic
membrane surface. The FYYD spanning helix of FXYD2b rests on the extracellular
membrane surface near but without contacting the β subunit (pink). The yellow box
marks the location of the intramembrane binding sites for Na+.
305X.-M. Gong et al. / Biochimica et Biophysica Acta 1848 (2015) 299–306study (Fig. 6). The model shows that the membrane surface location of
Arg and Lys in FXYD2b could signiﬁcantly contribute to the effective
electrostatic potential near the Na,K-ATPase's Na+ binding sites.
Molecular dynamics simulations indicate that speciﬁc arginine side
chains in channel voltage sensors can pair with one or more lipid phos-
phodiester groups at the membrane–water interface, dramatically
inﬂuencing the local electric ﬁeld [65]. This is consistent with the
requirement of negatively charged lipid phosphodiester groups for
channel function [66] and has provided an attractive explanation for
the voltage sensor mechanism. Similar requirements for negatively
charged phospholipids have been reported for optimal activity of the
Na,K-ATPase activity (see [67,68] and references therein).
Our data show that several arginines of FXYD2b appear to associate
with the lipid bilayer interfacial regions. In the presence of phospho-
lipids, they are sufﬁciently immobilized to yield both orientation-
dependent solid-state NMR signals as well as shifted solution NMR
signals. Their strategic positions in the structure of FXYD2b allows
their guanidinium groups to form hydrogen bonds with the phosphate
and polar head groups of membrane phospholipids, interactions that
could be particularly signiﬁcant in the presence of negatively charged
lipids such as phosphatidylserine. This property could be important
for the recruitment of speciﬁc phospholipids near theNa,K-ATPase, pro-
viding one potential explanation for the Na,K-ATPase stabilizing effect
of FXYD proteins [54,55], as well as for regulating the enzyme's activity.Acknowledgements
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